Skip to main content
Premium Trial:

Request an Annual Quote

Walter Narajowski

Walter Narajowski has joined the board of MDxHealth, the firm said. Currently senior vice president and general manager of Roka Bioscience, he has more than 25 years of experience in the medical diagnostics industry. Before Roka, Narajowski was CEO of Pathway Diagnostics, which was acquired by Quest Diagnostics in 2008. He has spent most of his career at Abbott Laboratories where he held various positions, including vice president, GM of critical care products; VP, GM of the infusion pump business; and GM of physician office diagnostics.

The company also announced that Mark Myslinksi has stepped down from its board after five years.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.